Transactions UK

  • June 11, 2025

    EQT, Sanofi Invest $135M In Spanish Biotech SpliceBio

    A group of investors led by Swedish private equity shop EQT and French pharmaceutical giant Sanofi said Wednesday they have invested $135 million in SpliceBio to help fund the development of its lead gene therapy candidate that will be used to treat a rare eye condition.

  • June 11, 2025

    Intuitive Investments Raises £9.6M For China Tech Business

    Intuitive Investments Group PLC said Wednesday it has raised £9.6 million ($13 million) with a new stock issue which it will use to fund its investment in Hui10 Inc., a technology company operating in China.

  • June 11, 2025

    Assura Backs Sweetened £1.7B KKR, Stonepeak Offer

    Healthcare property manager Assura said Wednesday that it has backed a sweetened £1.7 billion ($2.3 billion) final offer from U.S. private equity shops KKR and Stonepeak, ending a months-long bidding war with a British real estate investment trust.

  • June 10, 2025

    EU Says OK To $3.1B Intelsat-SES Merger

    Satellite titan SES SA's $3.1 billion plan to buy rival satellite operator Intelsat Holdings has won the approval of the European Commission, which has waved the merger through with no conditions.

  • June 10, 2025

    Most M&A Dealmakers Are Targeting AI Acquisitions

    Corporate and private equity dealmakers are rapidly integrating artificial intelligence into their mergers and acquisitions strategies, with 51% having acquired an AI business and 46% planning to do so soon, according to a new Norton Rose Fulbright report.

  • June 10, 2025

    Cloud Biz SoftwareOne To Close $1.4B Buy Of IT Consultancy

    SoftwareOne said Tuesday that it has fulfilled all the closing conditions of its voluntary takeover of Crayon Group, as the Swiss cloud technology company nears completion of the deal worth an estimated $1.4 billion.

  • June 10, 2025

    French REIT Buys Lyon Shopping Center For €146M

    Mercialys SA said Tuesday that it has acquired the Saint-Genis 2 shopping center in the second-largest consumer market in France for €146 million ($167 million) "to reinforce its position as a key player in the French retail property sector."

  • June 10, 2025

    Advent To Buy Stake In Ireland's Felix Pharma For $175M

    U.S. private equity shop Advent said that it plans to buy a minority stake in Irish pet medicines business Felix Pharmaceuticals for $175 million, to capitalize on growing demand for generic drugs in the animal health sector.

  • June 10, 2025

    Ashurst-Led Tech Tool-Maker To Sell Quantum Biz For £60M

    Oxford Instruments said on Tuesday that it has agreed to sell its quantum technology business to a U.S. manufacturer of products and services for research for up to £60 million ($81 million) to focus on its remaining business, in a deal guided by Ashurst LLP.

  • June 10, 2025

    FirstGroup Reveals Additional £50M Share Buyback

    FirstGroup PLC said Tuesday it will reward investors with an additional two-part £50 million share repurchase program as the public transport provider reported revenue of £1.4 billion.

  • June 10, 2025

    Mishcon De Reya Guides REIT On £11M Leisure Park Buy

    AEW UK, a real estate investment trust, said Tuesday it has bought a leisure park in the city of Leicester, central England, for approximately £11.2 million ($15 million).

  • June 10, 2025

    FCA Unveils Rules For Private Stock Market Launch

    The Financial Conduct Authority set out rules on Tuesday for its world-first regulated stock market for private companies in the latest bid by Britain to boost growth and provide alternatives to London's ailing equity capital market.

  • June 09, 2025

    Legal, Compliance Heads Named In Mallinckrodt-Endo Merger

    Ahead of finalizing their $6.7 billion merger, Ireland's Mallinckrodt PLC and Pennsylvania-based Endo Inc. announced that Mallinckrodt's current chief legal officer and Endo's chief compliance officer will be a part of the executive team that will drive the formation of what the companies said will be a global pharmaceutical industry leader.

  • June 09, 2025

    Media Biz Chair Who Misled Investors Told To Buy Out Shares

    The chairman of a media company has been ordered to buy out a minority shareholder after a London appeals court said Monday that he had deliberately deceived investors about his attempts to work towards selling the company.

  • June 09, 2025

    Precision Tools Co. Spectris To Back £3.7B Advent PE Bid

    Spectris, a British manufacturer of high-tech instruments, said Monday that it would probably back a proposed £3.7 billion ($5 billion) takeover offer from U.S. private equity company Advent International Corp., a deal in which the company would withdraw its listing from the London Stock Exchange.

  • June 09, 2025

    A&O Shearman-Led L'Oréal To Buy Majority Stake In Medik8

    L'Oréal SA said Monday that it has agreed to acquire a majority stake in British premium skincare brand Medik8 from European private equity firm Inflexion as the cosmetics giant seeks to expand its top-end brand Luxe.

  • June 09, 2025

    Paul Weiss-Led Computer Biz IonQ To Buy UK Rival For $1B

    Quantum computing company IonQ Inc. said Monday that it has agreed to acquire Oxford Ionics Ltd. for approximately $1.08 billion in a deal guided by Paul Weiss and Hogan Lovells that could bring "breakthroughs in quantum computing."

  • June 09, 2025

    Broking Group Howden Buys Peruvian Reinsurance Biz

    Howden Group said Monday that it has bought Peruvian reinsurance broker Innova Re, marking a further broadening of the insurance broking giant's footprint in Latin America.

  • June 09, 2025

    NHS Contractor Completes Sale Of 3 Units To Stay Afloat

    Troubled NHS contractor Totally PLC said Monday that it has completed the sale of three subsidiaries after appointing administrators to help it avoid liquidation.

  • June 09, 2025

    Paul Weiss Guides Qualcomm's $2.4B Alphawave IP Takeover

    Semiconductor-maker Qualcomm Inc. said Monday that it will buy Alphawave IP for $2.4 billion in a deal that will pull the British chip designer from the London Stock Exchange.

  • June 09, 2025

    Pets At Home Kicks Off 1st Stage Of £25M Buyback

    Pets At Home began a stock repurchase program of up to £12.5 million ($17 million) on Monday, the first phase of a £25 million share buyback scheme expected to lower the share capital of the animal welfare business.

  • June 06, 2025

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen MGM and the owners of the "Addams Family" trademark sue a private equity firm, two Cambridge colleges file for injunctions against Pro-Palestine student protest groups and a former NBA player brings a claim against Orrick Herrington & Sutcliffe LLP.

  • June 06, 2025

    Labour Gov't Eases Carried Interest Rules On Fund Managers

    The Labour government has unveiled a series of concessions on changes to the tax rules for carried interest, the investment income passed onto fund managers, following a consultation on the plans.

  • June 06, 2025

    Taxation With Representation: Winston, Stibbe, Weil, Goodwin

    In this week's Taxation With Representation, Chart Industries Inc. and Flowserve Corp. merge, Aedifica NV and Cofinimmo NV unite, Sanofi buys Blueprint Medicines Corp., and Kimberly-Clark Corp. sells a majority stake in its international tissue business to Suzano.

  • June 06, 2025

    Simpson Thacher-Led Rosebank To Raise £1.14B For Buy

    Rosebank said Friday that it will raise up to £1.14 billion ($1.54 billion) in equity to partly fund the acquisition of Electrical Components International in a reverse takeover transaction, with plans to "double shareholders' investment in three to five years."

Expert Analysis

  • Unpacking The New Concept Of 'Trading Misfeasance'

    Author Photo

    In addition to granting one of the largest trading awards since the Insolvency Act was passed in 1986, the High Court recently introduced a novel claim for misfeasant trading in Wright v. Chappell, opening the door to liability for directors, even where insolvent liquidation or administration was not inevitable, say lawyers at Greenberg Traurig.

  • Opinion

    The FTC Needs To Challenge The Novo-Catalent Deal

    Author Photo

    Novo's acquisition of Catalent threatens to substantially lessen competition in the manufacturing and marketing of GLP-1 diabetes and obesity drugs, and the Federal Trade Commission should challenge it under a vertical theory of harm, as it aligns with last year's merger guidelines and the Fifth Circuit decision in Illumina, says attorney David Balto.

  • Complying With EU Commission's Joint Purchasing Rules

    Author Photo

    One year after the European Commission released its revised guidelines on horizontal cooperation agreements, attorneys at Crowell & Moring reflect on the various forms such agreements can take, and how parties can avoid structuring arrangements that run afoul of competition law.

  • Tips For Implementing EU Sustainability Reporting Guidance

    Author Photo

    Lawyers at Sullivan & Cromwell discuss the European Financial Reporting Advisory Group’s recently published guidance on double materiality assessments and offer takeaways on achieving a sustainability directive-compliant process that could enhance clarity and consistency among multinational stakeholders.

  • What UK Digital Markets Act Will Mean For Competition Law

    Author Photo

    The new Digital Markets Act’s reforms will strengthen the Competition and Markets Authority's investigatory and enforcement powers across its full remit of merger control and antitrust investigations, representing a seismic shift in the U.K. competition and consumer law landscape, say lawyers at Travers Smith.

  • What French Watchdog Ruling Means For M&A Landscape

    Author Photo

    Although ultimately dismissed due to lack of evidence, the French competition authority’s recent post-closing review of several nonreportable mergers is a landmark case that highlights the increased complexity of such transactions, and is further testament to the European competition authorities’ willingness to expand their toolkit to address below-threshold M&As, say lawyers at Cleary.

  • Exploring The EU's Draft Standards On Crypto Authorization

    Author Photo

    The European Securities and Markets Authority’s recently published draft standards aim to promote fair competition and a safer environment for crypto providers and investors, detailing precisely the information to be provided to national authorities in charge of screening the acquisitions of a qualifying holding, says Mathieu de Korvin at Norton Rose.

  • What The New Digital Markets Bill Will Mean For Companies

    Author Photo

    The recently passed Digital Markets, Competition and Consumer Bill will bring significant reform to U.K. merger control and antitrust rules for all businesses, but the introduction of a strategic market status regime and its reporting obligations means large tech organizations in particular need to think carefully about the forthcoming changes, say lawyers at Linklaters.

  • Insurance Ruling Stresses High Hurdle To Fix Policy Wording

    Author Photo

    In Project Angel v. Axis, the Court of Appeal recently refused to rewrite the exclusion clause of an insurance policy, reminding parties in the warranty and indemnity market to carefully word clauses, as there is a high threshold before courts will intervene to amend policies, say Joseph Moore and Laura McCann at Travers Smith.

  • CMA Reports Signal Tighter Scrutiny Of AI Model Markets

    Author Photo

    The Competition and Markets Authority’s recent reports on artificial intelligence foundation models suggest that competition in AI is not working as it should, so large digital firms can expect the regulator to use its full toolbox as it continues to monitor and investigate the sector, say lawyers at Cooley.

  • How Gov't Response Addresses Investment Act Concerns

    Author Photo

    The government’s recently published response to a call for evidence on the National Security and Investment Act is largely appropriate to stakeholder concerns raised and demonstrates in its five areas of focus that it is willing to respond to live issues, say lawyers at Watson Farley.

  • Pharma Remains A Key Focus Of EU Antitrust Enforcement

    Author Photo

    The recently published European Commission report on pharmaceutical sector competition law illustrates that effective enforcement of EU rules remains a matter of high priority for EU and national authorities, say lawyers at Dechert.

  • The Dangers Of Providing Misleading Info In A Merger Review

    Author Photo

    Although Kingspan's recent proposed acquisition of Trimo, brought before the European Commission, was abandoned following investigation for an alleged breach of EU Merger Regulation requirements, it has brought to light the importance of submitting accurate and complete information in merger reviews to avoid incurring a substantial fine, say lawyers at Steptoe.

  • Cum-Ex Prosecutions Storm Shows No Sign Of Abating

    Author Photo

    The ongoing trial of Sanjay Shah in Denmark is a clear indicator that efforts remain focused on holding to account the alleged architects and beneficiaries of cum-ex trading, and with these prosecutions making their way across Europe, it is a more turbulent time now than ever, says Niall Hearty at Rahman Ravelli.

  • Spartan Arbitration Tactics Against Well-Funded Opponents

    Author Photo

    Like the ancient Spartans who held off a numerically superior Persian army at the Battle of Thermopylae, trial attorneys and clients faced with arbitration against an opponent with a bigger war chest can take a strategic approach to create a pass to victory, say Kostas Katsiris and Benjamin Argyle at Venable.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Transactions UK archive.